Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancer
American Association for Cancer Research • 97th Annual Meeting 1 ...
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.
Giancarlo Antonini-Cappellini's research works
Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls
Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls
Giancarlo Antonini (@gcarloantonini) / Twitter
Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing in: European Journal of Endocrinology Volume 182 Issue 1 (2020)
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with T
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
Genomic Classification of Cutaneous Melanoma. - Abstract - Europe PMC
Genomic Classification of Cutaneous Melanoma - ScienceDirect
Untitled
ioo;;-~~ ." - ,
Giancarlo CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Ecco i finalisti del Premio Roma di letteratura - Il Faro Online
TRIDENT analysis of melanoma vs control sera.
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Dr. Michael A. Davies, MD | Houston, TX | Oncologist | US News Doctors
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
